Disease Info Card

Mitral Valve Insufficiency

Information about Mitral Valve Insufficiency: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Mitral Valve Insufficiency

Most recent studies have shown that Mitral Valve Insufficiency shares some biological mechanisms with aortic-valve-insufficiency, aortic-valve-stenosis, atrial-fibrillation, blepharoptosis, cardiac-fibrillation, cardiomyopathies, endocarditis, heart-diseases, heart-failure, heart-valve-disease, infarction, mitral-valve-prolapse-syndrome, mitral-valve-stenosis, myocardial-infarction, regurgitation, rheumatic-heart-disease, rheumatism, stenosis, tricuspid-valve-insufficiency, ventricular-dysfunction-left.

Among the many pathways, these few ones have gauged particular interests from scientists studying Mitral Valve Insufficiency, and have been seen in publications frequently: Aging, Blood Circulation, Coagulation, Dehiscence, Diuresis, Excretion, Glomerular Filtration, Hemostasis, Inflammatory Response, Localization, Pathogenesis, Platelet Activation, Platelet Aggregation, Reflex, Secretion, Segmentation, Transport, Transposition, Vasoconstriction, Vasodilation

Quite a number of genes have been found to play important roles in Mitral Valve Insufficiency, such as ACE, AKR1B1, AR, AREG, CALCR, CALR, CPB1, FDXR, GNL3, KRAS, MVP, NDUFB6, NPPB, PRB1, SLC6A8. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.